{"cdcTestId":"2022-0044","testcaseName":"Patient is 9 years of age and is administered Moderna\u0027s Covid-19 (CVX 221) vaccine as a second dose at an interval of 8 weeks","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2013-08-24T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2022-06-13T20:00:00","dateUpdated":"2022-10-19T12:18:49.684","generalDescription":"This test cases describes when a patient that is 9 years of age is administered a second dose of Moderna\u0027s Covid-19 (CVX Code 221) vaccine at an interval of 8 weeks, that the dose is valid.  Another dose should be forecast.","changedInVersion":"4.28","reasonForChange":"v4.28 Updated the test cased based on new updated Interim Clinical Considerations for a new COVID-19 booster recommendation for people ages 5 years and older to receive 1 bivalent MRNA booster dose, at least 2 months, after completion of a monovalent primary series; these recommendations replace all booster recommendations for this age group."}